UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018602
Receipt number R000021528
Scientific Title Isolated tumor cell in lung cancer operation, multi center, prospective, observational study
Date of disclosure of the study information 2015/08/08
Last modified on 2024/02/13 09:39:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Isolated tumor cell in lung cancer operation, multi center, prospective, observational study

Acronym

Isolated tumor cell in lung cancer operation, ILO1501

Scientific Title

Isolated tumor cell in lung cancer operation, multi center, prospective, observational study

Scientific Title:Acronym

Isolated tumor cell in lung cancer operation, ILO1501

Region

Japan


Condition

Condition

lung cancer

Classification by specialty

Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to know the prognostic factor aroun lung cancer operation using isolated tumor cell.

Basic objectives2

Others

Basic objectives -Others

observational study

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

detection of isolated tumor cell using Screen Cell method

Key secondary outcomes

relation of isolated tumor cell and pathological factor
relation of isolated tumor cell and operation time


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Preoperative diagnosis as primary non small cell lung cancer
2.clinical stage, T1b-T2, N0M0
3.lobectomy, bi-lobectomy or pneumonectomy
4.consolidation/GGO ratio > 50%
5.ECOG PS0,1
6. chemotherapy naive
7. having operabirity

Key exclusion criteria

1. other active malingant tumor
2. HBV, HCV, HIV
3. fever up over 38
4. having steroid therapy

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Noriyoshi Sawabata

Organization

Hoshigaoca Medical Center

Division name

thoracic surgery

Zip code


Address

4-8-1 Hoshigaoka, Maikata city, Osaka, Japan

TEL

06-6879-2595

Email

nsawabata@hotmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Noriyuki Matsutani

Organization

Teikyo University School of Medicine

Division name

Surgery

Zip code


Address

2-11-1 Kaga, Itabashi-ku Tokyo, Japan

TEL

03-3964-1231

Homepage URL


Email

matsutan@med.teikyo-u.ac.jp


Sponsor or person

Institute

Hoshigaoca Medical Center

Institute

Department

Personal name



Funding Source

Organization

B 25293301

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

星ヶ丘医療センター(大阪府)
山形県立中央病院(山形県)
九州がんセンター(福岡県)
帝京大学(東京都)
浜松医大(静岡県)
順天堂大学(東京都)
東京医大(東京都)
済生会横浜市南部病院(神奈川県)
大阪大学(大阪府)


Other administrative information

Date of disclosure of the study information

2015 Year 08 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 06 Month 02 Day

Date of IRB

2015 Year 06 Month 11 Day

Anticipated trial start date

2015 Year 08 Month 01 Day

Last follow-up date

2016 Year 07 Month 31 Day

Date of closure to data entry

2016 Year 07 Month 31 Day

Date trial data considered complete

2016 Year 08 Month 31 Day

Date analysis concluded

2016 Year 08 Month 31 Day


Other

Other related information

isolated tumor cell using Screen Cell method
pathological factor
operative factor


Management information

Registered date

2015 Year 08 Month 08 Day

Last modified on

2024 Year 02 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021528


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name